APA (7th ed.) Citation

R, A., KI, N., Y, Y., KS, T., & Y, S. (2022). Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P-glycoprotein induction and inhibition in the intestine, liver, and kidney. CPT: pharmacometrics & systems pharmacology, 11(7), 919. https://doi.org/10.1002/psp4.12807

Chicago Style (17th ed.) Citation

R, Asaumi, Nunoya KI, Yamaura Y, Taskar KS, and Sugiyama Y. "Robust Physiologically Based Pharmacokinetic Model of Rifampicin for Predicting Drug-drug Interactions via P-glycoprotein Induction and Inhibition in the Intestine, Liver, and Kidney." CPT: Pharmacometrics & Systems Pharmacology 11, no. 7 (2022): 919. https://doi.org/10.1002/psp4.12807.

MLA (9th ed.) Citation

R, Asaumi, et al. "Robust Physiologically Based Pharmacokinetic Model of Rifampicin for Predicting Drug-drug Interactions via P-glycoprotein Induction and Inhibition in the Intestine, Liver, and Kidney." CPT: Pharmacometrics & Systems Pharmacology, vol. 11, no. 7, 2022, p. 919, https://doi.org/10.1002/psp4.12807.